Marshall Wace
AGN

Marshall Wace’s Allergan plc AGN Stock Holding History

Marshall Wace’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000,000
Closed -$177M – 2125
2020
Q1 		$177M Buy
1,000,000
+523,799
+110% +$98.6M 1.77% 4
2019
Q4 		$91M Sell
476,201
-37,170
-7% -$6.71M 0.63% 20
2019
Q3 		$86.4M Buy
513,371
+401,820
+360% +$65.5M 0.68% 17
2019
Q2 		$18.7M Buy
+111,551
New +$15.4M 0.15% 140
2018
Q4 		– Sell
-12,798
Closed -$2.44M – 1910
2018
Q3 		$2.44M Buy
12,798
+10,503
+458% +$1.93M 0.02% 631
2018
Q2 		$383K Buy
+2,295
New +$368K 0.01% 605
2017
Q4 		– Sell
-11,927
Closed -$2.44M – 510
2017
Q3 		$2.44M Buy
+11,927
New +$2.77M 0.11% 149
2017
Q1 		– Sell
-135,999
Closed -$28.6M – 884
2016
Q4 		$28.6M Buy
135,999
+134,843
+11,665% +$27.9M 0.19% 148
2016
Q3 		$266K Sell
1,156
-5,045
-81% -$1.23M ﹤0.01% 868
2016
Q2 		$1.43M Sell
6,201
-138,456
-96% -$31.9M 0.01% 655
2016
Q1 		$38.8M Sell
144,657
-347,854
-71% -$99.6M 0.37% 70
2015
Q4 		$154M Sell
492,511
-156,326
-24% -$46.5M 1.44% 7
2015
Q3 		$176M Buy
648,837
+250,094
+63% +$76.8M 2.17% 3
2015
Q2 		$121M Sell
398,743
-229,554
-37% -$68.5M 1.58% 5
2015
Q1 		$187M Buy
628,297
+429,765
+216% +$123M 2.44% 2
2014
Q4 		$51.1M Buy
198,532
+99,638
+101% +$24.9M 0.67% 26
2014
Q3 		$23.9M Sell
98,894
-5,278
-5% -$1.18M 0.34% 81
2014
Q2 		$23.2M Buy
+104,172
New +$21.6M 0.34% 79

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Marshall Wace's AGN Position: Q2 2020 in Review

Marshall Wace sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,000,000 shares — an estimated $177M sold.

Marshall Wace first reported a position in AGN in Q2 2014 and held it in 18 quarters. The position peaked at $187M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Marshall Wace reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Marshall Wace sold 1,000,000 Allergan plc shares in Q2 2020, an estimated $177M.
  • Marshall Wace first reported a position in Allergan plc in Q2 2014 and held it in 18 quarters.
  • Marshall Wace's Allergan plc position peaked at $187M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.